The DOI matches its Crossref record.
β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
Abstract
Deleterious effects on the heart from chronic stimulation of beta-adrenergic receptors (betaARs), members of the 7 transmembrane receptor family, have classically been shown to result from Gs-dependent adenylyl cyclase activation. Here, we identify a new signaling mechanism using both in vitro and in vivo systems whereby beta-arrestins mediate beta1AR signaling to the EGFR. This beta-arrestin-dependent transactivation of the EGFR, which is independent of G protein activation, requires the G protein-coupled receptor kinases 5 and 6. In mice undergoing chronic sympathetic stimulation, this novel signaling pathway is shown to promote activation of cardioprotective pathways that counteract the effects of catecholamine toxicity. These findings suggest that drugs that act as classical antagonists for G protein signaling, but also stimulate signaling via beta-arrestin-mediated cytoprotective pathways, would represent a novel class of agents that could be developed for multiple members of the 7 transmembrane receptor family.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 58
- Rockman, 2002, Nature., 415, 206, 10.1038/415206a · DOI · Paper page
- Koch, 2000, Annu. Rev. Physiol., 62, 237, 10.1146/annurev.physiol.62.1.237 · DOI · Paper page
- Lefkowitz, 1998, J. Biol. Chem., 273, 18677, 10.1074/jbc.273.30.18677 · DOI · Paper page
- Luttrell, 2001, Proc. Natl. Acad. Sci. U. S. A., 98, 2449, 10.1073/pnas.041604898 · DOI · Paper page
- Maudsley, 2000, J. Biol. Chem., 275, 9572, 10.1074/jbc.275.13.9572 · DOI · Paper page
- Wei, 2003, Proc. Natl. Acad. Sci. U. S. A., 100, 10782, 10.1073/pnas.1834556100 · DOI · Paper page
- Kim, 2005, Proc. Natl. Acad. Sci. U. S. A., 102, 1442, 10.1073/pnas.0409532102 · DOI · Paper page
- Luttrell, 2005, J. Mol. Neurosci., 26, 253, 10.1385/JMN:26:2-3:253 · DOI
- Daub, 1996, Nature., 379, 557, 10.1038/379557a0 · DOI · Paper page
- Prenzel, 1999, Nature., 402, 884, 10.1038/47260 · DOI · Paper page
- Shah, 2004, Trends Endocrinol. Metab., 15, 241, 10.1016/j.tem.2004.06.011 · DOI
- Werry, 2005, Trends Endocrinol. Metab., 16, 26, 10.1016/j.tem.2004.11.008 · DOI
- Luttrell, 1997, J. Biol. Chem., 272, 4637, 10.1074/jbc.272.7.4637 · DOI · Paper page
- Zwick, 1997, J. Biol. Chem., 272, 24767, 10.1074/jbc.272.40.24767 · DOI · Paper page
- Huang, 2006, Mol. Cell., 21, 737, 10.1016/j.molcel.2006.02.018 · DOI · Paper page
- Tanos, 2006, J. Biol. Chem., 281, 32714, 10.1074/jbc.M603126200 · DOI
- Rapacciuolo, 2003, J. Biol. Chem., 278, 35403, 10.1074/jbc.M305675200 · DOI
- Lefkowitz, 2005, Science., 308, 512, 10.1126/science.1109237 · DOI · Paper page
- Luttrell, 1999, Science., 283, 655, 10.1126/science.283.5402.655 · DOI · Paper page
- Ahn, 2004, J. Biol. Chem., 279, 7807, 10.1074/jbc.C300443200 · DOI · Paper page
- Laporte, 1999, Proc. Natl. Acad. Sci. U. S. A., 96, 3712, 10.1073/pnas.96.7.3712 · DOI · Paper page
- Naga Prasad, 2002, J. Cell Biol., 158, 563, 10.1083/jcb.200202113 · DOI · Paper page
- Kovoor, 1999, J. Biol. Chem., 274, 6831, 10.1074/jbc.274.11.6831 · DOI · Paper page
- Violin, 2006, J. Biol. Chem., 281, 20577, 10.1074/jbc.M513605200 · DOI
- Pitcher, 1998, Annu. Rev. Biochem., 67, 653, 10.1146/annurev.biochem.67.1.653 · DOI · Paper page
- Eguchi, 2003, Biochem. Soc. Trans., 31, 1198, 10.1042/bst0311198 · DOI
- Thomas, 2004, Cell. Mol. Life Sci., 61, 2687, 10.1007/s00018-004-4245-2 · doi:10.1007/s00018-004-4245-2
- Carpenter, 2000, Sci. STKE., 2000, PE1, 10.1126/stke.2000.18.pe1 · DOI · Paper page
- Crone, 2002, Nat. Med., 8, 459, 10.1038/nm0502-459 · DOI · Paper page
- Gassmann, 1995, Nature., 378, 390, 10.1038/378390a0 · DOI · Paper page
- Lee, 1995, Nature., 378, 394, 10.1038/378394a0 · DOI · Paper page
- Iwamoto, 2003, Proc. Natl. Acad. Sci. U. S. A., 100, 3221, 10.1073/pnas.0537588100 · DOI · Paper page
- Yoshioka, 2005, Proc. Natl. Acad. Sci. U. S. A., 102, 10622, 10.1073/pnas.0501198102 · DOI
- Rockman, 1998, J. Biol. Chem., 273, 18180, 10.1074/jbc.273.29.18180 · DOI · Paper page
- Koch, 1995, Science., 268, 1350, 10.1126/science.7761854 · DOI · Paper page
- Engelhardt, 1999, Proc. Natl. Acad. Sci. U. S. A., 96, 7059, 10.1073/pnas.96.12.7059 · DOI · Paper page
- Luttrell, 2003, J. Mol. Endocrinol., 30, 117, 10.1677/jme.0.0300117 · DOI
- Natarajan, 2006, Methods Mol. Biol., 332, 51
- DeFea, 2000, J. Cell Biol., 148, 1267, 10.1083/jcb.148.6.1267 · DOI · Paper page
- Ahn, 2004, J. Biol. Chem., 279, 35518, 10.1074/jbc.M405878200 · DOI · Paper page
- Luttrell, 2004, Oncogene., 23, 7969, 10.1038/sj.onc.1208162 · DOI · Paper page
- Fischer, 2003, Biochem Soc. Trans., 31, 1203, 10.1042/bst0311203 · DOI · Paper page
- Pierce, 2001, J. Biol. Chem., 276, 23155, 10.1074/jbc.M101303200 · DOI · Paper page
- Storez, 2005, J. Biol. Chem., 280, 40210, 10.1074/jbc.M508001200 · DOI
- Shenoy, 2006, J. Biol. Chem., 281, 1261, 10.1074/jbc.M506576200 · DOI · Paper page
- Ren, 2005, Proc. Natl. Acad. Sci. U. S. A., 102, 1448, 10.1073/pnas.0409534102 · DOI · Paper page
- Fabian, 2005, Nat. Biotechnol., 23, 329, 10.1038/nbt1068 · DOI · Paper page
- Kang, 2000, Circ. Res., 86, 1107, 10.1161/01.RES.86.11.1107 · DOI · Paper page
- Communal, 1999, Circulation., 100, 2210, 10.1161/01.CIR.100.22.2210 · DOI · Paper page
- 10.1172/JCI200316326 · DOI
- Shenoy, 2007, Circ. Res., 100, 1142, 10.1161/01.RES.0000261939.88744.5a · DOI
- Thomas, 2002, Circ. Res., 90, 135, 10.1161/hh0202.104109 · DOI · Paper page
- Asakura, 2002, Nat. Med., 8, 35, 10.1038/nm0102-35 · DOI · Paper page
- Naga Prasad, 2005, Nat. Cell Biol., 7, 785, 10.1038/ncb1278 · DOI
- 10.1172/JCI25397 · DOI · Paper page
- Esposito, 2002, Circulation., 105, 85, 10.1161/hc0102.101365 · DOI · Paper page
- 10.1172/JCI200318213 · doi:10.1172/jci200318213
- Rabindran, 2005, Cancer Lett., 227, 9, 10.1016/j.canlet.2004.11.015 · DOI
Cited by
The Sympathetic Nervous System in Heart Failure
Triposkiadis, F., Karayannis, G., Giamouzis, G., Skoularigis, J., Louridas, G., & Butler, J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.015 · Cited by 978
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 825
Self-citationRose, B. A., Force, T., & Wang, Y. (2010) · Physiological Reviews · doi:10.1152/physrev.00054.2009 · Cited by 723
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., & Lefkowitz, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707936104 · Cited by 597
Self-citationMolecular Mechanism of β-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
Reiter, E., Ahn, S., Shukla, A. K., & Lefkowitz, R. J. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105800 · Cited by 583
Self-citationTherapeutic potential of β-arrestin- and G protein-biased agonists
Whalen, E. J., Rajagopal, S., & Lefkowitz, R. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.11.004 · Cited by 510
Self-citationAnimal Models of Heart Failure: A Scientific Statement From the American Heart Association
Houser, S. R., Margulies, K. B., Murphy, A. M., Spinale, F. G., Francis, G. S., Prabhu, S. D., Rockman, H. A., Kass, D. A., Molkentin, J. D., Sussman, M. A., et al. (2012) · Circulation Research · doi:10.1161/res.0b013e3182582523 · Cited by 435
Self-citationThe Diverse Roles of Arrestin Scaffolds in G Protein–Coupled Receptor Signaling
Peterson, Y. K., & Luttrell, L. M. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013367 · Cited by 422
Tackling heart failure in the twenty-first century
Mudd, J. O., & Kass, D. A. (2008) · Nature · doi:10.1038/nature06798 · Cited by 406
Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics
Chen, M. H., Kerkelä, R., & Force, T. (2008) · Circulation · doi:10.1161/circulationaha.108.776831 · Cited by 379
GPCR desensitization: Acute and prolonged phases
Rajagopal, S., & Shenoy, S. K. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2017.01.024 · Cited by 374
Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
Luttrell, L. M., Gesty-Palmer, D., & Sibley, D. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002436 · Cited by 369
Force, T., & Kolaja, K. L. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3252 · Cited by 363
Expression and Function of the Epidermal Growth Factor Receptor in Physiology and Disease
Chen, J., Zeng, F., Forrester, S. J., Eguchi, S., Zhang, M.-Z., & Harris, R. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00030.2015 · Cited by 327
Self-citationG-Protein–Coupled Receptors in Heart Disease
Wang, J., Gareri, C., & Rockman, H. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.311403 · Cited by 303
Self-citationThe β-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors
Smith, J. S., & Rajagopal, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.713313 · Cited by 294
Biased Receptor Signaling in Drug Discovery
Kenakin, T. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.016790 · Cited by 294
G Protein–Coupled Receptor Signaling Through β-Arrestin–Dependent Mechanisms
Jean-Charles, P.-Y., Kaur, S., & Shenoy, S. K. (2017) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000482 · Cited by 280
β-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivation
Kim, I.-M., Tilley, D. G., Chen, J., Salazar, N. C., Whalen, E. J., Violin, J. D., & Rockman, H. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804745105 · Cited by 276
Self-citationNew Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging
Lucia, C. D., Eguchi, A., & Koch, W. J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00904 · Cited by 274
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
Gallo, S., Vitacolonna, A., Bonzano, A., Comoglio, P., & Crepaldi, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092164 · Cited by 264
Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats
Deschamps, A. M., & Murphy, E. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00283.2009 · Cited by 252
Balakumar, P., & Jagadeesh, G. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.06.011 · Cited by 182
Bär, C., de Jesus, B. B., Serrano, R., Tejera, A., Ayuso, E., Jimenez, V., Formentini, I., Bobadilla, M., Mizrahi, J., de Martino, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6863 · Cited by 162
Critical roles of STAT3 in β-adrenergic functions in the heart
Zhang, W., Qu, X., Chen, B., Snyder, M., Wang, M., Li, B., Tang, Y., Chen, H., Zhu, W., Zhan, L., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017472 · Cited by 67
Taglieri, D. M., Monasky, M. M., Knezevic, I., Sheehan, K. A., Lei, M., Wang, X., Chernoff, J., Wolska, B. M., Ke, Y., & Solaro, R. J. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.09.016 · Cited by 62
Targeting G protein coupled receptor-related pathways as emerging molecular therapies
Ghanemi, A. (2015) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2013.07.007 · Cited by 53
Gao, M., Zhan, Y.-Q., Yu, M., Ge, C.-H., Li, C.-Y., Zhang, J.-H., Wang, X.-H., Ge, Z.-Q., & Yang, X.-M. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.04.013 · Cited by 52
Kinase inhibitor screening using artificial neural networks and engineered cardiac biowires
Conant, G., Ahadian, S., Zhao, Y., & Radisic, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-12048-5 · Cited by 25
Metadata
- Authors
- Noma, T., Lemaire, A., Naga Prasad, S. V., Barki-Harrington, L., Tilley, D. G., Chen, J., Le Corvoisier, P., Violin, J. D., Wei, H., Lefkowitz, R. J., & Rockman, H. A.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-09-04
- Volume
- 117
- Issue
- 9
- Pages
- 2445-2458
- ISSN
- 0021-9738
- Cited by
- 418
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.